Literature DB >> 10933149

Local blood flow regulation in transplanted rat pancreatic islets: influence of adenosine, angiotensin II, and nitric oxide inhibition.

R Olsson1, L Jansson, A Andersson, P O Carlsson.   

Abstract

BACKGROUND: Transplanted islets lack endothelial cells immediately after implantation and therefore depend on an adequate revascularization for their survival and function. However, the functional properties of the newly formed islet graft microvessels are largely unknown. This study aimed to investigate the blood flow regulation of transplanted pancreatic islets.
METHODS: Pancreatic islets were syngeneically transplanted beneath the renal capsule of control and streptozotocin-diabetic rats. Blood flow measurements were performed 4 weeks later using laser-Doppler flowmetry. Adenosine (0.6 mg x kg(-1) x min(-1), angiotensin II (AT II; 0.17 microg x kg(-1) x min(-1)) and the nitric oxide synthase inhibitor NG-nitro-L-arginine (25 mg/ kg) were given to each animal.
RESULTS: An increased basal blood flow and basal vascular conductance in the islet grafts, but not in the renal cortex, were seen in diabetic rats compared with control rats. Adenosine increased, and AT II decreased, the vascular conductance of the islet grafts in both nondiabetic and diabetic animals. A more pronounced circulatory response to AT II was observed in kidneys of diabetic animals, whereas there was no difference in the islet graft blood flow response between nondiabetic and diabetic animals. NG-Nitro-L-arginine decreased islet graft blood flow and vascular conductance in both nondiabetic and diabetic recipients, but the effect was more pronounced in the non-diabetic animals.
CONCLUSIONS: Islet graft blood flow was influenced by adenosine, AT II, and nitric oxide inhibition in all animals. However, diabetic animals were less dependent on nitric oxide to maintain a basal blood flow in the islet graft.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933149     DOI: 10.1097/00007890-200007270-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets.

Authors:  T Lau; P-O Carlsson; P S Leung
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

2.  Adenosine receptor activation ameliorates type 1 diabetes.

Authors:  Zoltán H Németh; David Bleich; Balázs Csóka; Pál Pacher; Jon G Mabley; Leonóra Himer; E Sylvester Vizi; Edwin A Deitch; Csaba Szabó; Bruce N Cronstein; György Haskó
Journal:  FASEB J       Date:  2007-04-03       Impact factor: 5.191

Review 3.  Islet vasculature as a regulator of endocrine pancreas function.

Authors:  Nikiforos Ballian; F Charles Brunicardi
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

4.  The Pericyte of the Pancreatic Islet Regulates Capillary Diameter and Local Blood Flow.

Authors:  Joana Almaça; Jonathan Weitz; Rayner Rodriguez-Diaz; Elizabeth Pereira; Alejandro Caicedo
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

5.  Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts.

Authors:  C Kampf; T Lau; R Olsson; P S Leung; P-O Carlsson
Journal:  Diabetologia       Date:  2005-05-05       Impact factor: 10.122

6.  Markedly decreased blood perfusion of pancreatic islets transplanted intraportally into the liver: disruption of islet integrity necessary for islet revascularization.

Authors:  Johanna Henriksnäs; Joey Lau; Guangxiang Zang; Per-Olof Berggren; Martin Köhler; Per-Ola Carlsson
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

7.  Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets.

Authors:  Johan Olerud; Magnus Johansson; Jack Lawler; Nils Welsh; Per-Ola Carlsson
Journal:  Diabetes       Date:  2008-04-16       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.